High Grade Osteosarcoma
Oncology·MeSH: Osteosarcoma
Prevalence
5.0 / 100K
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cabozantinib S-malate | Valneva SE (VALN) |
Phase 2(1)
Frequently asked questions
How many drugs are in development for High Grade Osteosarcoma?
BioSniper tracks 2 drugs in development for High Grade Osteosarcoma across 2 companies.
How many clinical trials target High Grade Osteosarcoma?
There are 1 clinical trial targeting High Grade Osteosarcoma tracked by BioSniper.
What is the prevalence of High Grade Osteosarcoma?
The estimated prevalence of High Grade Osteosarcoma is approximately 5.0 per 100,000 population.
Deep-dive into High Grade Osteosarcoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis